STAT
NOVEMBER 20, 2024
WASHINGTON — People close to Robert F. Kennedy Jr. are exploring a proposal that could upend how physician payment is determined in America, four sources familiar with the process told STAT.
BioPharma Dive
NOVEMBER 20, 2024
Pfizer will work with Ampersand Biomedicines and Montai Therapeutics to find drugs for obesity and lung cancer, respectively, adding to collaborations it previously formed with other Flagship startups.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
NOVEMBER 20, 2024
Doctors have been using needles as a way to inject people with drugs since the 1600s. Today they’re often used for biologic drugs, which are too large to deliver via pills because they would be dissolved by stomach acid. Now a group of bioengineers is hoping to give drug delivery an update with a device that draws inspiration from cuttlefish and other sea creatures.
The Pharmacist
NOVEMBER 20, 2024
Antibiotic use rose by 2.4% year-on-year in 2023 and prescribing levels are now in line with those seen in 2019, according to national surveillance data published by the UK Health Security Agency (UKHSA). The increases were seen across the majority of antibiotic groups, with penicillins accounting for the most frequently prescribed antibiotic group in primary […] The post Latest UKHSA figures show rise in both antibiotic use and resistance appeared first on The Pharmacist.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
NOVEMBER 20, 2024
Kura Oncology has signed a global partnership with the Japanese drugmaker Kyowa Kirin to develop and sell Kura’s experimental treatment for acute leukemia, the companies said Wednesday. Kyowa is paying $320 million to Kura in exchange for global licensing rights to the drug, called ziftomenib, which is in a late-stage clinical trial for a genetically defined type of advanced leukemia.
pharmaphorum
NOVEMBER 20, 2024
MSD's subcutaneous formulation of top-selling cancer drug Keytruda was non-inferior to the current intravenous version in a head-to-head trial
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharmacy Joe
NOVEMBER 20, 2024
In this episode, I’ll discuss peripheral IV administration of 3% sodium chloride solution. Episode 976: Are there times when 3% (hypertonic) sodium chloride can be given through a peripheral IV? Subscribe on iTunes , Android , or Stitcher Infusions of 3% sodium chloride are routinely recommended to be given through central, not peripheral IV lines. This recommendation is based on the theory that since the osmolarity of 3% sodium chloride exceeds 900 mOsm/L, it puts the patient at risk of thrombo
STAT
NOVEMBER 20, 2024
Tonya Brand was horrified to find a piece of metal poking out of her inner thigh while relaxing at her house in Georgia in 2011. She had no idea what it could be. It was only after extensive imaging that her doctors realized what had happened: A medical device that had been implanted in her two years earlier to catch blood clots had broken and was now migrating to different parts of her body.
Express Pharma
NOVEMBER 20, 2024
On 19 November 2024, Lupin announced the launch of Bumetanide Injection USP in the United States following approval from the United States Food and Drug Administration (FDA). The product is available in two formulations: 1 mg/4 mL (0.25 mg/mL) single-dose vials and 2.5 mg/10 mL (0.25 mg/mL) multiple-dose vials. Bumetanide Injection USP is a generic equivalent of Bumex Injection (0.25 mg/mL) by Validus Pharmaceuticals, LLC.
STAT
NOVEMBER 20, 2024
Schrödinger CEO Ramy Farid wants you to know that his company isn’t an AI company…but he’ll call it that if you want to. The company, founded in 1990, started out by making software that used the basic laws of physics to laboriously and exactly predict how molecules will interact with each other in space. Those calculations, rooted in the field of computational physics, needed lots of expensive and time-consuming computing power to run, and many people abandoned those t
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Express Pharma
NOVEMBER 20, 2024
AVPN, the largest network of social investors in Asia, has launched the “Climate x Health: Lighthouse for Asia” Fund with support from the Bayer Foundation. Announced during the Singapore Pavilion session at COP29 in Baku, Azerbaijan, the USD 5-million fund aims to assist non-profit organisations utilising climate innovations to develop scalable solutions to protect vulnerable communities from the health impacts of climate change.
STAT
NOVEMBER 20, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we meet Pfizer’s new chief scientific officer, ponder why the stock for Silence Therapeutics dropped despite promising data, and see that pharma executives aren’t too worried about Robert F.
Pharmaceutical Technology
NOVEMBER 20, 2024
The UK’s NICE has rejected a deal for the reimbursement of Daiichi Sankyo and AstraZeneca's breast cancer drug Enhertu for the third time.
STAT
NOVEMBER 20, 2024
Pfizer said its chief oncology officer, Chris Boshoff, will head all of the company’s research and development efforts in addition to keeping his current duties overseeing the company’s scientific and commercial efforts in cancer. Boshoff replaces Mikael Dolsten, who led research and development at the drug giant for 15 years and who announced his plans to retire in July.
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Pharma Times
NOVEMBER 20, 2024
The Netherlands facility is designed to handle a wide range of nanomedicines, including lipid-based nanoparticles
STAT
NOVEMBER 20, 2024
A stroke, a traumatic brain injury — at any moment, any one of us could leave behind our normal state of consciousness and start to require ’round-the-clock care. Sometimes, a patient displays regular cycles of wakefulness and sleep without regaining the capacity for normal voluntary action. This is a tragic situation for the patient’s family — but what, if anything, might the patient themselves be experiencing?
Pharmaceutical Technology
NOVEMBER 20, 2024
UK Health Secretary Wes Streeting outlaid the key shifts needed to fix a “fragmented” NHS at the Jefferies London Healthcare Conference.
STAT
NOVEMBER 20, 2024
When Randi Johnson was undergoing treatment for breast cancer, her husband, Brian, often felt at a loss to help. But then, when he and Randi met with a surgeon to discuss reconstructing her breast, he was struck by something he could do. The Midwestern father of five, a lifelong tinkerer, decided to make his wife the best possible prosthetic nipple.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
pharmaphorum
NOVEMBER 20, 2024
Sage Therapeutics' run of bad news has continued with a failed phase 2 trial of dalzanemdor as a treatment for Huntington's disease
STAT
NOVEMBER 20, 2024
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not particularly appealing. And what better way to make the time fly than to keep busy.
The Pharmacist
NOVEMBER 20, 2024
What more can we do to improve men’s health? Pharmacist Michael Achiampong shares his personal viewpoint about improving the health of men and boys. Men and boys’ health – physical, mental and emotional – has rocketed up the healthcare agenda and public awareness like never before.1,2 There is new impetus for some long-running initiatives such as Movember3 […] The post We should call for a new minister to improve men and boys’ health appeared first on The Pharmacist.
pharmaphorum
NOVEMBER 20, 2024
Discussions aimed at making AstraZeneca and Daiichi Sankyo's Enhertu available to breast cancer patients on the NHS have been abandoned
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
The Pharmacist
NOVEMBER 20, 2024
The ongoing closure of community pharmacies across the country is a ‘grave concern’ that should be further investigated by MPs, Lord Ara Darzi has told an inquiry today. The cancer surgeon and former Labour minister was this morning questioned by the Health and Social Care Committee on the findings of his major investigation into the […] The post Lord Darzi: Pharmacy closures ‘a grave concern’ that must be investigated by MPs appeared first on The Pharmacist.
Outsourcing Pharma
NOVEMBER 20, 2024
From discovering her knack for chemistry in high school to proving her expertise in male-dominated spaces, Tran Pham has built a dynamic career in biopharma.
Pharmafile
NOVEMBER 20, 2024
20 November 2024 – Glasgow, UK –: Glox Therapeutics, a company pioneering the development of precision antibiotic therapies based on naturally occurring bacteriocins, today announced it has secured £1 million in grant funding from PACE (Pathways to Antimicrobial Clinical Efficacy), one of the UK’s largest public-private initiatives targeting early-stage antimicrobial medicines and diagnostic discovery.
Outsourcing Pharma
NOVEMBER 20, 2024
From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harringtonâs journey is one of resilience and curiosity.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
BioPharma Dive
NOVEMBER 20, 2024
Built around research by Stanford scientist Carolyn Bertozzi and MIT researcher Jessica Stark, Valora Therapeutics is designing drugs to target glyco-immune checkpoints.
pharmaphorum
NOVEMBER 20, 2024
Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the EU
BioPharma Dive
NOVEMBER 20, 2024
Negative results from a Huntington’s trial add to a calamitous year for Sage, which last month decided to overhaul its research, reconfigure its executive team and lay off a third of its staff.
National Association of Boards of Pharmacy
NOVEMBER 20, 2024
In January 2024, NABP launched the NAPLEX Advantage assessment tool which provides colleges of pharmacy and students with a testing experience that mimics the North American Pharmacist Licensure Examination® (NAPLEX®). Like the NAPLEX, the NAPLEX Advantage is administered in a secure and proctored environment. Comprised of 100 questions that were previously used on the NAPLEX, the NAPLEX Advantage is built using the same examination blueprint as the NAPLEX.
FDA Law Blog: Biosimilars
NOVEMBER 20, 2024
By Adrienne R. Lenz, Principal Medical Device Regulation Expert & Kristy Katzenmeyer-Pleuss, Regulatory and Biological Safety Consultant* — FDA recently issued a draft guidance, Chemical Analysis for Biocompatibility Assessment of Medical Devices , which describes chemical characterization methods that may be used to demonstrate biocompatibility of a medical device as an alternative to conducting certain biological testing.
Expert insights. Personalized for you.
337 
Let's personalize your content